213 related articles for article (PubMed ID: 17632233)
1. Exacerbation of myoclonus by memantine in a patient with Alzheimer disease.
Papageorgiou SG; Kontaxis T; Antelli A; Kalfakis N
J Clin Psychopharmacol; 2007 Aug; 27(4):407-8. PubMed ID: 17632233
[No Abstract] [Full Text] [Related]
2. Memantine-related psychotic symptoms in a patient with bipolar disorder.
Canan F; Ataoglu A
J Clin Psychiatry; 2010 Jul; 71(7):957. PubMed ID: 20667296
[No Abstract] [Full Text] [Related]
3. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
4. Memantine for patients with Alzheimer disease.
Finucane TE
JAMA; 2004 Apr; 291(14):1695; author reply 1695. PubMed ID: 15082684
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
Bullock R
Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232
[TBL] [Abstract][Full Text] [Related]
6. First drug for moderate-to-severe Alzheimer's.
FDA Consum; 2004; 38(1):3. PubMed ID: 15032183
[No Abstract] [Full Text] [Related]
7. [Little behavior improvement with memantine].
Potz-Biedermann C
Med Monatsschr Pharm; 2005 Nov; 28(11):413-4. PubMed ID: 16309030
[No Abstract] [Full Text] [Related]
8. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
[No Abstract] [Full Text] [Related]
9. [Cholesterol inhibitor and memantine in symptomatic dementia therapy].
Rodda J; Carter J
Praxis (Bern 1994); 2013 Feb; 102(5):293-300; discussion 298-9. PubMed ID: 23446240
[No Abstract] [Full Text] [Related]
10. Memantine (Ebixa) in clinical practice - results of an observational study.
Calabrese P; Essner U; Forstl H
Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714
[TBL] [Abstract][Full Text] [Related]
11. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
12. Memantine for dementia?
Drug Ther Bull; 2003 Oct; 41(10):73-6. PubMed ID: 14593973
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer disease and its management: a review.
Samanta MK; Wilson B; Santhi K; Kumar KP; Suresh B
Am J Ther; 2006; 13(6):516-26. PubMed ID: 17122533
[TBL] [Abstract][Full Text] [Related]
14. UK government guidance on Alzheimer's drugs postponed.
O'Neill MF
Drug Discov Today; 2005 Sep; 10(17):1132. PubMed ID: 16182201
[No Abstract] [Full Text] [Related]
15. [Mechanisms of action of Alzheimer medications].
Alhainen K
Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
[No Abstract] [Full Text] [Related]
16. Memantine: a new approach to Alzheimer's disease.
Keltner NL; Williams B
Perspect Psychiatr Care; 2004; 40(3):123-4. PubMed ID: 15515294
[No Abstract] [Full Text] [Related]
17. Memantine in the treatment of dementia.
Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
[No Abstract] [Full Text] [Related]
18. Alzheimer's disease: will advances made in the past turn the tide?
Semla TP
Ann Pharmacother; 2007 Sep; 41(9):1494-6. PubMed ID: 17666576
[No Abstract] [Full Text] [Related]
19. Dementia.
Warner J; Butler R; Arya P
Clin Evid; 2004 Dec; (12):1361-90. PubMed ID: 15865724
[No Abstract] [Full Text] [Related]
20. Discontinuing donepezil or starting memantine for Alzheimer's disease.
Suzuki T
N Engl J Med; 2012 Jun; 366(23):2227-8; author reply 2228. PubMed ID: 22670911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
